title: [Percutaneous radiofrequency ablation in treatment of advanced local lung cancer: clinical analysis of 78 cases].
abstract: OBJECTIVE
  To investigate the efficacy and safety of radiofrequency ablation (RFA) in treatment of advanced lung cancer.
  
  
  METHODS
  Seventy-eight patients with advanced local lung cancer were treated with RFA at the temperature from 70 degrees C to 90 degrees C under local or intravenous anesthesia under CT scan for 8 minutes to 26 minutes. 103 times of RFA were done in 78 patients, 19 of them being treated twice and 2 treated tree times. Followed up was conducted for 1 - 6 months. The outcomes were evaluated by plain and contrast spiral CT scanning.
  
  
  RESULTS
  During RFA 32 patients felt pain, and 18 patients experienced cough and hemoptysis. After RFA pneumothorax was seen in 18 of the patients, and contrast spiral CT scanning showed devascularization and/or reduction of tumor size in 67 lesions.
  
  
  CONCLUSIONS
  Removing tumor load rapidly and with excellent short-term outcome, percutaneous RAF is safe to treat advanced local lung cancer.
authors.affiliation: Department of Imaging and Interventional Radiology, Cancer Hospital, Sun Yat-sen University, Guangzhou 510060, China.
authors.forename: Zi-lin
authors.initials: ZL
authors.lastname: Huang
authors.forename: Pei-hong
authors.initials: PH
authors.lastname: Wu
authors.forename: Ming
authors.initials: M
authors.lastname: Zhao
authors.forename: Wang
authors.initials: W
authors.lastname: Li
authors.forename: Wei-jun
authors.initials: WJ
authors.lastname: Fan
authors.forename: Fu-jun
authors.initials: FJ
authors.lastname: Zhang
authors.forename: Jin-hua
authors.initials: JH
authors.lastname: Huang
authors.forename: Yang-kui
authors.initials: YK
authors.lastname: Gu
mesh_terms: D000230:Adenocarcinoma / Q000473:pathology / Q000628:therapy; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017115:Catheter Ablation / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D055752:Small Cell Lung Carcinoma / Q000473:pathology / Q000628:therapy